Home > News > Taking the NanoPulse -- Nano-boom? Or Nano-bust?
August 26th, 2009
Taking the NanoPulse -- Nano-boom? Or Nano-bust?
Scott E. Rickert: Times are tough all over. Banks, carmakers, retailers -- they're all taking body blows in this economy. And everyone in my business knows a nanotechnology company or two that's struggling. Still, it was a punch in the stomach when I read six news stories in one afternoon about seemingly healthy nano-companies being suddenly in trouble. Deep trouble. Chapter 11, Chapter 7, delistings, layoffs, locked doors.
Some media pundits were quick to announce the death of nanotechnology. And there were shock waves that rolled through the industry.
But these are companies whose technology and leadership I know. The sound bites weren't enough. Is it any wonder I wanted to get to the bottom of the story?
News and information
Detecting Cancer Earlier is Goal of Rutgers-Developed Medical Imaging Technology: Rare earth nanocrystals and infrared light can reveal small cancerous tumors and cardiovascular lesions October 21st, 2014
Nitrogen Doped Graphene Characterized by Iranian, Russian, German Scientists October 21st, 2014
Physicists build reversible laser tractor beam October 20th, 2014
Removal of Limitations of Composites at Superheat Temperatures October 20th, 2014
Secretary Vilsack Announces Partnership to Advance Commercial Potential of Cellulosic Nanomaterial from Wood December 11th, 2013
Cutting Away at the NRC's Research Capability December 6th, 2013
Project aims to mass-produce 'nanopetals' for sensors, batteries October 22nd, 2013
Governor Cuomo Announces 'Nano Utica' $1.5 Billion Public-Private Investment That Will Make the Mohawk Valley New York's Next Major Hub of Nanotech Research October 12th, 2013
Nanodevices for clinical diagnostic with potential for the international market: The development is based on optical principles and provides precision and allows saving vital time for the patient October 15th, 2014
Aculon Receives Patent for Application of Enhanced Bonding Layers on Titanium October 9th, 2014
harmaEngine will join Nanobiotix’ pivotal trial for NBTXR3 in Soft Tissue Sarcoma to accelerate its development in Asia-Pacific: PharmaEngine to make milestone payment to Nanobiotix in October 2014 to recognize the value created October 8th, 2014
‘Small’ transformation yields big changes September 16th, 2014